BEN vs CNS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 18, 2026

BEN

54.8
AI Score
VS
BEN Wins

CNS

47.7
AI Score

Investment Advisor Scores

BEN

55score
Recommendation
HOLD

CNS

48score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric BEN CNS Winner
Revenue 6.98B 94.41M BEN
Net Income 695.20M 29.96M BEN
Net Margin 10.0% 31.7% CNS
Operating Income 820.10M 36.29M BEN
ROE 5.9% 9.9% CNS
ROA 1.9% 6.7% CNS
Total Assets 36.24B 450.12M BEN
Free Cash Flow 283.50M 4.31M BEN

Relative Price Performance (Last 90 Days)

BEN 1M: +6.3% · 3M: +11.2% CNS 1M: +1.8% · 3M: +12.8%

Current Technical Phase

BEN

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.1% over 20 days), RSI 56

RSI (14): 56.3 · Price: $34.31

CNS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 47.9 · Price: $81.42

Fundamentals Snapshot

Metric BEN CNS
Market Cap
Forward P/E 10.8 20.5
Trailing P/E 23.1 25.0
Revenue (TTM)
Revenue Growth 0.1% 0.1%
Gross Margin 0.4% 0.5%
Operating Margin 0.1% 0.3%
EPS 1.47 3.23
Dividend Yield 0.04% 0.03%

Frequently Asked Questions

Based on our detailed analysis, BEN is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.